787
Views
39
CrossRef citations to date
0
Altmetric
Review Article

Rodent-borne hemorrhagic fevers: under-recognized, widely spread and preventable – epidemiology, diagnostics and treatment

, , , , , , , , & show all
Pages 26-42 | Received 07 Dec 2011, Accepted 16 Apr 2012, Published online: 07 Jun 2012

References

  • CDC report. (1994). Bolivian hemorrhagic fever, El Beni Department, Bolivia, MMWR Morb. Mortal. Wkly. Rep. 43, 943–946.
  • CDC report. (1994). Re-emergence of Bolivian hemorrhagic fever. Epidemiol Bull, 15, 4–5.
  • CDC report. (1997). Outbreak of leptospirosis among white-water rafters--Costa Rica, MMWR Morb.Mortal.Wkly.Rep. 46, 577–579.
  • Abu Sin M, Stark K, van Treeck U, Dieckmann H, Uphoff H, Hautmann W, Bornhofen B, Jensen E, Pfaff G, Koch J. (2007). Risk factors for hantavirus infection in Germany, 2005. Emerging Infect Dis, 13, 1364–1366.
  • Aguilar PV, Camargo W, Vargas J, Guevara C, Roca Y, Felices V, Laguna-Torres VA, Tesh R, Ksiazek TG, Kochel TJ. (2009). Reemergence of Bolivian hemorrhagic fever, 2007-2008. Emerging Infect Dis, 15, 1526–1528.
  • Ahmed A, Engelberts MF, Boer KR, Ahmed N, Hartskeerl RA. (2009). Development and validation of a real-time PCR for detection of pathogenic Leptospira species in clinical materials. PLoS ONE, 4, e7093.
  • Aitichou M, Saleh SS, McElroy AK, Schmaljohn C, Ibrahim MS. (2005). Identification of Dobrava, Hantaan, Seoul, and Puumala viruses by one-step real-time RT-PCR. J Virol Methods, 124, 21–26.
  • Alexeyev OA, Morozov VG, Efremov AG, Settergren B. (1994). A case of haemorrhagic fever with renal syndrome complicated by spleen haemorrhage. Scand J Infect Dis, 26, 491–492.
  • Alves AP, Moura DC, Spolti GP. (2011). Co-infection with hepatitis A and leptospirosis in the Amazon region: report of two cases. Trop Gastroenterol, 32, 234–236.
  • Amorosa V, MacNeil A, McConnell R, Patel A, Dillon KE, Hamilton K, Erickson BR, Campbell S, Knust B, Cannon D, Miller D, Manning C, Rollin PE, Nichol ST. (2010). Imported Lassa fever, Pennsylvania, USA, 2010. Emerging Infect Dis, 16, 1598–1600.
  • Armstrong LR, Zaki SR, Goldoft MJ, Todd RL, Khan AS, Khabbaz RF, Ksiazek TG, Peters CJ. (1995). Hantavirus pulmonary syndrome associated with entering or cleaning rarely used, rodent-infested structures. J Infect Dis, 172, 1166.
  • Bahr U, Zeier M, Muranyi W. (2006). Characterization of a new Puumala virus genotype associated with hemorrhagic fever with renal syndrome. Virus Genes, 33, 229–234.
  • Bannister B. (2010). Viral haemorrhagic fevers imported into non-endemic countries: risk assessment and management. Br Med Bull, 95, 193–225.
  • Barcellos C, Sabroza PC. (2001). The place behind the case: leptospirosis risks and associated environmental conditions in a flood-related outbreak in Rio de Janeiro. Cad Saude Publica, 17 Suppl, 59–67.
  • Barwick RS, Mohammed HO, McDonough PL, White ME. (1998). Epidemiologic features of equine Leptospira interrogans of human significance. Prev Vet Med, 36, 153–165.
  • Bausch DG, Hadi CM, Khan SH, Lertora JJ. (2010). Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever. Clin Infect Dis, 51, 1435–1441.
  • Behera B, Chaudhry R, Pandey A, Mohan A, Dar L, Premlatha MM, Gupta E, Broor S, Aggarwal P. (2010). Co-infections due to Leptospira, dengue and hepatitis E: a diagnostic challenge. J Infect Dev Ctries, 4, 48–50.
  • Abela-Ridder B, Sikkema R, Hartskeerl RA. (2010). Estimating the burden of human leptospirosis. Int J Antimicrob Agents, 36 Suppl 1, S5–S7.
  • Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, Levett PN, Gilman RH, Willig MR, Gotuzzo E, Vinetz JM; Peru-United States Leptospirosis Consortium. (2003). Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis, 3, 757–771.
  • Bi Z, Formenty PB, Roth CE. (2008). Hantavirus infection: a review and global update. J Infect Dev Ctries, 2, 3–23.
  • Bonner PC, Schmidt WP, Belmain SR, Oshin B, Baglole D, Borchert M. (2007). Poor housing quality increases risk of rodent infestation and Lassa fever in refugee camps of Sierra Leone. Am J Trop Med Hyg, 77, 169–175.
  • Bowen MD, Rollin PE, Ksiazek TG, Hustad HL, Bausch DG, Demby AH, Bajani MD, Peters CJ, Nichol ST. (2000). Genetic diversity among Lassa virus strains. J Virol, 74, 6992–7004.
  • Braun JR, Herting J, Kisters K, Winterberg B. (2001). Blurred vision as chief complaint in nephropathia epidemica. Clin Nephrol, 55, 89–90.
  • Brett-Major, DM. & Coldren, R. (2012). “Antibiotics for leptospirosis”, Cochrane. Database. Syst. Rev, 2, CD008264.
  • Brett-Major, DM. Lipnick, RJ. (2009). Antibiotic prophylaxis for leptospirosis. Cochrane Database. Syst. Rev, 3, CD007342.
  • Broom JC, Alston JM. (1948). Weil’s disease; analysis of 195 cases in England. Lancet, 3, 96.
  • Brummer-Korvenkontio M, Henttonen H, Vaheri A. (1982). Hemorrhagic fever with renal syndrome in Finland: ecology and virology of nephropathia epidemica. Scand J Infect Dis Suppl, 36, 88–91.
  • Cantoni G, Padula P, Calderón G, Mills J, Herrero E, Sandoval P, Martinez V, Pini N, Larrieu E. (2001). Seasonal variation in prevalence of antibody to hantaviruses in rodents from southern Argentina. Trop Med Int Health, 6, 811–816.
  • Carballal G, Videla CM, Merani MS. (1988). Epidemiology of Argentine hemorrhagic fever. Eur J Epidemiol, 4, 259–274.
  • Chapman LE, Mertz GJ, Peters CJ, Jolson HM, Khan AS, Ksiazek TG, Koster FT, Baum KF, Rollin PE, Pavia AT, Holman RC, Christenson JC, Rubin PJ, Behrman RE, Bell LJ, Simpson GL, Sadek RF. (1999). Intravenous ribavirin for hantavirus pulmonary syndrome: safety and tolerance during 1 year of open-label experience. Ribavirin Study Group. Antivir Ther (Lond), 4, 211–219.
  • Charrel RN, de Lamballerie X. (2003). Arenaviruses other than Lassa virus. Antiviral Res, 57, 89–100.
  • Charrel RN, de Lamballerie X. (2010). Zoonotic aspects of arenavirus infections. Vet Microbiol, 140, 213–220.
  • Chen JP, Cosgriff TM. (2000). Hemorrhagic fever virus-induced changes in hemostasis and vascular biology. Blood Coagul Fibrinolysis, 11, 461–483.
  • Chirathaworn C, Chantaramalai T, Sereemaspun A, Kongthong NSuwancharoen D. (2009). Detection of Leptospira in urine using anti-Leptospira-coated gold nanoparticles. Comp Immunol Microbiol Infect Dis, 34(1), 31–34.
  • Chun PK, Godfrey LJ. (1984). Unique selective right atrial hemorrhage with epidemic (Korean) hemorrhagic fever. Am Heart J, 108, 410–412.
  • Clement J, Heyman P, McKenna P, Colson P, Avsic-Zupanc T. (1997). The hantaviruses of Europe: from the bedside to the bench. Emerging Infect Dis, 3, 205–211.
  • Clement J, Maes P, Lagrou K, Van Ranst M, Lameire N. (2012). A unifying hypothesis and a single name for a complex globally emerging infection: hantavirus disease. Eur J Clin Microbiol Infect Dis, 31, 1–5.
  • Clement JP, Crowcroft NS, Maes P, Van Loock F, Colson P, Van Ranst M. (2011). Smoking and other risk factors for hantavirus infections: the whole story. Epidemiol Infect, 139, 1284–5; author reply 1285.
  • Colebunders R, Van Esbroeck M, Moreau M, Borchert M. (2002). Imported viral haemorrhagic fever with a potential for person-to-person transmission: review and recommendations for initial management of a suspected case in Belgium. Acta Clin Belg, 57, 233–240.
  • Cosgriff TM. (1991). Mechanisms of disease in Hantavirus infection: pathophysiology of hemorrhagic fever with renal syndrome. Rev Infect Dis, 13, 97–107.
  • Crouzet J, Faucher JF, Toubin M, Hoen B, Estavoyer JM. (2011). Serum C-reactive protein (CRP) and procalcitonin (PCT) levels and kinetics in patients with leptospirosis. Eur J Clin Microbiol Infect Dis, 30, 299–302.
  • Cummins D. (1990). Lassa fever. Br J Hosp Med, 43, 186–8, 190, 192.
  • Cvetko L, Turk N, Markotic A, Milas Z, Margaletic J, Miletic-Medved M, Plyusnin A, Baranton G, Postic D, Avsic-Zupanc T. (2006). Short report: dual infections with Puumala virus and Leptospira interrogans serovar lora in a bank vole (Clethrionomys glareolus). Am J Trop Med Hyg, 74, 612–614.
  • De Geus A, Wolff JWTimmer VE. (1977). Clinical leptospirosis in Kenya (1): a clinical study in Kwale District, Cost Province. East Afr Med J, 54, 115–124.
  • de Manzione N, Salas RA, Paredes H, Godoy O, Rojas L, Araoz F, Fulhorst CF, Ksiazek TG, Mills JN, Ellis BA, Peters CJ, Tesh RB. (1998). Venezuelan hemorrhagic fever: clinical and epidemiological studies of 165 cases. Clin Infect Dis, 26, 308–313.
  • Demby AH, Chamberlain J, Brown DW, Clegg CS. (1994). Early diagnosis of Lassa fever by reverse transcription-PCR. J Clin Microbiol, 32, 2898–2903.
  • Dietl CA, Wernly JA, Pett SB, Yassin SF, Sterling JP, Dragan R, Milligan K, Crowley MR. (2008). Extracorporeal membrane oxygenation support improves survival of patients with severe Hantavirus cardiopulmonary syndrome. J Thorac Cardiovasc Surg, 135, 579–584.
  • Diglisic G, Xiao SY, Gligic A, Obradovic M, Stojanovic R, Velimirovic D, Lukac V, Rossi CA, LeDuc JW. (1994). Isolation of a Puumala-like virus from Mus musculus captured in Yugoslavia and its association with severe hemorrhagic fever with renal syndrome. J Infect Dis, 169, 204–207.
  • Drosten C, Kümmerer BM, Schmitz H, Günther S. (2003). Molecular diagnostics of viral hemorrhagic fevers. Antiviral Res, 57, 61–87.
  • Duncan C, Krafsur G, Podell B, Baeten LA, LeVan I, Charles B, Ehrhart EJ. (2012). Leptospirosis and tularaemia in raccoons (Procyon lotor) of Larimer Country, Colorado. Zoonoses Public Health, 59, 29–34.
  • Dutta TK, Christopher M. (2005). Leptospirosis–an overview. J Assoc Physicians India, 53, 545–551.
  • Edington GM, White HA. (1972). The pathology of Lassa fever. Trans R Soc Trop Med Hyg, 66, 381–389.
  • Emmerich P, Thome-Bolduan C, Drosten C, Gunther S, Ban E, Sawinsky I, Schmitz H. (2006). Reverse ELISA for IgG and IgM antibodies to detect Lassa virus infections in Africa. J Clin Virol, 37, 277–281.
  • Enria DA, Briggiler AM, Sánchez Z. (2008). Treatment of Argentine hemorrhagic fever. Antiviral Res, 78, 132–139.
  • Enria DA, Maiztegui JI. (1994). Antiviral treatment of Argentine hemorrhagic fever. Antiviral Res, 23, 23–31.
  • Enria DA, Pinheiro F. (2000). Rodent-borne emerging viral zoonosis. Hemorrhagic fevers and hantavirus infections in South America. Infect Dis Clin North Am, 14, 167–84, x.
  • Escutenaire S, Pastoret PP. (2000). Hantavirus infections. Rev - Off Int Epizoot, 19, 64–78.
  • Everard CO, Edwards CN, Everard JD, Carrington DG. (1995). A twelve-year study of leptospirosis on Barbados. Eur J Epidemiol, 11, 311–320.
  • Farr RW. (1994). Hantavirus pulmonary syndrome. W V Med J, 90, 422–425.
  • Ferluga D, Vizjak A. (2008). Hantavirus nephropathy. J Am Soc Nephrol, 19, 1653–1658.
  • Ferreira MS, Nishioka S, Santos TL, Santos RP, Santos PS, Rocha A. (2000). Hantavirus pulmonary syndrome in Brazil: clinical aspects of three new cases. Rev Inst Med Trop Sao Paulo, 42, 41–46.
  • Fichet-Calvet E, Rogers DJ. (2009). Risk maps of Lassa fever in West Africa. PLoS Negl Trop Dis, 3, e388.
  • Fisher-Hoch SP. (2005). Lessons from nosocomial viral haemorrhagic fever outbreaks. Br Med Bull, 73-74, 123–137.
  • Frame JD. (1989). Clinical features of Lassa fever in Liberia. Rev Infect Dis, 11 Suppl 4, S783–S789.
  • Frame JD, Casals J, Dennis EA. (1979). Lassa virus antibodies in hospital personnel in western Liberia. Trans R Soc Trop Med Hyg, 73, 219–224.
  • Galloway RL, Levett PN, Tumeh JW, Flowers CR. (2009). Assessing cost effectiveness of empirical and prophylactic therapy for managing leptospirosis outbreaks. Epidemiol Infect, 137, 1323–1332.
  • Gasparetto EL, Davaus T, Escuissato DL, Marchiori E. (2007). Hantavirus pulmonary syndrome: high-resolution CT findings in one patient. Br J Radiol, 80, e21–e23.
  • Gaynor K, Katz AR, Park SY, Nakata M, Clark TA, Effler PV. (2007). Leptospirosis on Oahu: an outbreak associated with flooding of a university campus. Am J Trop Med Hyg, 76, 882–885.
  • Geisbert TW, Jones S, Fritz EA, Shurtleff AC, Geisbert JB, Liebscher R, Grolla A, Ströher U, Fernando L, Daddario KM, Guttieri MC, Mothé BR, Larsen T, Hensley LE, Jahrling PB, Feldmann H. (2005). Development of a new vaccine for the prevention of Lassa fever. PLoS Med, 2, e183.
  • Godoy P, Marsac D, Stefas E, Ferrer P, Tischler ND, Pino K, Ramdohr P, Vial P, Valenzuela PD, Ferrés M, Veas F, López-Lastra M. (2009). Andes virus antigens are shed in urine of patients with acute hantavirus cardiopulmonary syndrome. J Virol, 83, 5046–5055.
  • Gonçalves FG, Jovem CL, Isac VM, Neves PO. (2010). High-resolution computed tomography findings in hantavirus pulmonary syndrome. J Thorac Imaging, 25, W33–W35.
  • Gouveia EL, Metcalfe J, de Carvalho AL, Aires TS, Villasboas-Bisneto JC, Queirroz A, Santos AC, Salgado K, Reis MG, Ko AI. (2008). Leptospirosis-associated severe pulmonary hemorrhagic syndrome, Salvador, Brazil. Emerging Infect Dis, 14, 505–508.
  • Grcevska L, Polenakovic M, Oncevski A, Zografski D, Gligic A. (1990). Different pathohistological presentations of acute renal involvement in Hantaan virus infection: report of two cases. Clin Nephrol, 34, 197–201.
  • Griffith ME, Hospenthal DR, Murray CK. (2006). Antimicrobial therapy of leptospirosis. Curr Opin Infect Dis, 19, 533–537.
  • Gui XE, Ho M, Cohen MS, Wang QL, Huang HP, Xie QX. (1987). Hemorrhagic fever with renal syndrome: treatment with recombinant alpha interferon. J Infect Dis, 155, 1047–1051.
  • Guidugli F, Castro AA, Atallah AN. (2000). Antibiotics for preventing leptospirosis. Cochrane Database Syst Rev, 4, CD001305.
  • Günther S, Emmerich P, Laue T, Kühle O, Asper M, Jung A, Grewing T, ter Meulen J, Schmitz H. (2000). Imported lassa fever in Germany: molecular characterization of a new lassa virus strain. Emerging Infect Dis, 6, 466–476.
  • Gurjar M, Saigal S, Baronia AK, Azim A, Poddar B, Singh RK. (2011). Clinical manifestations of co-infection with malaria and leptospirosis. Trop Doct, 41, 175–178.
  • Guron G, Holmdahl J, Dotevall L. (2006). Acute renal failure after a holiday in the tropics. Clin Nephrol, 66, 468–471.
  • Haake DA, Dundoo M, Cader R, Kubak BM, Hartskeerl RA, Sejvar JJ, Ashford DA. (2002). Leptospirosis, water sports, and chemoprophylaxis. Clin Infect Dis, 34, e40–e43.
  • Haas WH, Breuer T, Pfaff G, Schmitz H, Köhler P, Asper M, Emmerich P, Drosten C, Gölnitz U, Fleischer K, Günther S. (2003). Imported Lassa fever in Germany: surveillance and management of contact persons. Clin Infect Dis, 36, 1254–1258.
  • Hadi CM, Goba A, Khan SH, Bangura J, Sankoh M, Koroma S, Juana B, Bah A, Coulibaly M, Bausch DG. (2010). Ribavirin for Lassa fever postexposure prophylaxis. Emerging Infect Dis, 16, 2009–2011.
  • Hansman D, Murphy AM, Wannan JS, Woolard TJ, Boger JR. (1966). Q fever, brucellosis and leptospirosis among abattoir workers in New South Wales. Med J Aust, 2, 20–23.
  • Hardestam J, Lundkvist A, Klingström J. (2009). Sensitivity of Andes hantavirus to antiviral effect of human saliva. Emerging Infect Dis, 15, 1140–1142.
  • Hart CA, Bennett M. (1999). Hantavirus infections: epidemiology and pathogenesis. Microbes Infect, 1, 1229–1237.
  • Heller MV, Marta RF, Sturk A, Maiztegui JI, Hack CE, Cate JW, Molinas FC. (1995). Early markers of blood coagulation and fibrinolysis activation in Argentine hemorrhagic fever. Thromb Haemost, 73, 368–373.
  • Heyman P, Baert K, Plyusnina A, Cochez C, Lundkvist A, Esbroeck MV, Goossens E, Vandenvelde C, Plyusnin A, Stuyck J. (2009). Serological and genetic evidence for the presence of Seoul hantavirus in Rattus norvegicus in Flanders, Belgium. Scand J Infect Dis, 41, 51–56.
  • Heyman P, Plyusnina A, Berny P, Cochez C, Artois M, Zizi M, Pirnay JP, Plyusnin A. (2004). Seoul hantavirus in Europe: first demonstration of the virus genome in wild Rattus norvegicus captured in France. Eur J Clin Microbiol Infect Dis, 23, 711–717.
  • Hindfelt B. (1989). Nephropathia epidemica encephalitis. Acta Neurol Scand, 79, 431.
  • Hjertqvist M, Klein SL, Ahlm C, Klingstrom J. (2010). Mortality rate patterns for hemorrhagic fever with renal syndrome caused by Puumala virus. Emerging Infect Dis, 16, 1584–1586.
  • Holmes GP, McCormick JB, Trock SC, Chase RA, Lewis SM, Mason CA, Hall PA, Brammer LS, Perez-Oronoz GI, McDonnell MK. (1990). Lassa fever in the United States. Investigation of a case and new guidelines for management. N Engl J Med, 323, 1120–1123.
  • Howard MJ, Doyle TJ, Koster FT, Zaki SR, Khan AS, Petersen EA, Peters CJ, Bryan RT. (1999). Hantavirus pulmonary syndrome in pregnancy. Clin Infect Dis, 29, 1538–1544.
  • Huggins JW, Hsiang CM, Cosgriff TM, Guang MY, Smith JI, Wu ZO, LeDuc JW, Zheng ZM, Meegan JM, Wang QN. (1991). Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J Infect Dis, 164, 1119–1127.
  • Hujakka H, Koistinen V, Kuronen I, Eerikäinen P, Parviainen M, Lundkvist A, Vaheri A, Vapalahti O, Närvänen A. (2003). Diagnostic rapid tests for acute hantavirus infections: specific tests for Hantaan, Dobrava and Puumala viruses versus a hantavirus combination test. J Virol Methods, 108, 117–122.
  • Jenison S, Hjelle B, Simpson S, Hallin G, Feddersen R, Koster F. (1995). Hantavirus pulmonary syndrome: clinical, diagnostic, and virologic aspects. Semin Respir Infect, 10, 259–269.
  • Jereb M, Lunacek NK, Kotar T, Saksida A, Petrovec M, Avšic-Županc T. (2011). Procalcitonin in hantavirus infections. Scand J Clin Lab Invest, 71, 287–291.
  • Jittapalapong S, Sittisan P, Sakpuaram T, Kabeya H, Maruyama S, Inpankaew T. (2009). Coinfection of Leptospira spp and Toxoplasma gondii among stray dogs in Bangkok, Thailand. Southeast Asian J Trop Med Public Health, 40, 247–252.
  • Jonsson CB, Figueiredo LT, Vapalahti O. (2010). A global perspective on hantavirus ecology, epidemiology, and disease. Clin Microbiol Rev, 23, 412–441.
  • Kallio ER, Begon M, Henttonen H, Koskela E, Mappes T, Vaheri A, Vapalahti O. (2009). Cyclic hantavirus epidemics in humans–predicted by rodent host dynamics. Epidemics, 1, 101–107.
  • Kanerva M, Paakkala A, Mustonen J, Paakkala T, Lahtela J, Pasternack A. (1996). Pulmonary involvement in nephropathia epidemica: radiological findings and their clinical correlations. Clin Nephrol, 46, 369–378.
  • Kariv R, Klempfner R, Barnea A, Sidi Y, Schwartz E. (2001). The changing epidemiology of leptospirosis in Israel. Emerging Infect Dis, 7, 990–992.
  • Kernéis S, Koivogui L, Magassouba N, Koulemou K, Lewis R, Aplogan A, Grais RF, Guerin PJ, Fichet-Calvet E. (2009). Prevalence and risk factors of Lassa seropositivity in inhabitants of the forest region of Guinea: a cross-sectional study. PLoS Negl Trop Dis, 3, e548.
  • Khan A, Khan AS. (2003). Hantaviruses: a tale of two hemispheres. Panminerva Med, 45, 43–51.
  • Khan AS, Khabbaz RF, Armstrong LR, Holman RC, Bauer SP, Graber J, Strine T, Miller G, Reef S, Tappero J, Rollin PE, Nichol ST, Zaki SR, Bryan RT, Chapman LE, Peters CJ, Ksiazek TG. (1996). Hantavirus pulmonary syndrome: the first 100 US cases. J Infect Dis, 173, 1297–1303.
  • Klempa B, Koivogui L, Sylla O, Koulemou K, Auste B, Krüger DH, ter Meulen J. (2010). Serological evidence of human hantavirus infections in Guinea, West Africa. J InfectDis, 201, 1031–1034.
  • Klempa B, Witkowski PT, Popugaeva E, Auste B, Koivogui L, Fichet-Calvet E, Strecker T, Ter Meulen J, Krüger DH. (2012). Sangassou virus, the first hantavirus isolate from Africa, displays genetic and functional properties distinct from those of other murinae-associated hantaviruses. J Virol, 86, 3819–3827.
  • Ko AI, Galvão Reis M, Ribeiro Dourado CM, Johnson WD Jr, Riley LW. (1999). Urban epidemic of severe leptospirosis in Brazil. Salvador Leptospirosis Study Group. Lancet, 354, 820–825.
  • Ko AI, Goarant C, Picardeau M. (2009). Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen. Nat Rev Microbiol, 7, 736–747.
  • Kudesia G, Christie P, Walker E, Pinkerton I, Lloyd G. (1988). Dual infection with Leptospira and hantavirus. Lancet, 1, 1397.
  • Kunz S. (2009). The role of the vascular endothelium in arenavirus haemorrhagic fevers. Thromb Haemost, 102, 1024–1029.
  • Lähdevirta J. (1982). Clinical features of HFRS in Scandinavia as compared with East Asia. Scand J Infect Dis Suppl, 36, 93–95.
  • Laine O, Mäkelä S, Mustonen J, Huhtala H, Szanto T, Vaheri A, Lassila R, Joutsi-Korhonen L. (2010). Enhanced thrombin formation and fibrinolysis during acute Puumala hantavirus infection. Thromb Res, 126, 154–158.
  • Lecompte E, Fichet-Calvet E, Daffis S, Koulémou K, Sylla O, Kourouma F, Doré A, Soropogui B, Aniskin V, Allali B, Kouassi Kan S, Lalis A, Koivogui L, Günther S, Denys C, ter Meulen J. (2006). Mastomys natalensis and Lassa fever, West Africa. Emerging Infect Dis, 12, 1971–1974.
  • Lee HW, Baek LJ, Johnson KM. (1982). Isolation of Hantaan virus, the etiologic agent of Korean hemorrhagic fever, from wild urban rats. J Infect Dis, 146, 638–644.
  • Lee M. (1987). Coagulopathy in patients with hemorrhagic fever with renal syndrome. J Korean Med Sci, 2, 201–211.
  • Leifer E, Gocke DJ, Bourne H. (1970). Lassa fever, a new virus disease of man from West Africa. II. Report of a laboratory-acquired infection treated with plasma from a person recently recovered from the disease. Am J Trop Med Hyg, 19, 677–679.
  • Levett PN. (2001). Leptospirosis. Clin Microbiol Rev, 14, 296–326.
  • Levett PN, Morey RE, Galloway RL, Turner DE, Steigerwalt AG, Mayer LW. (2005). Detection of pathogenic leptospires by real-time quantitative PCR. J Med Microbiol, 54, 45–49.
  • Linard C, Tersago K, Leirs H, Lambin EF. (2007). Environmental conditions and Puumala virus transmission in Belgium. Int J Health Geogr, 6, 55.
  • Linderholm M, Elgh F. (2001). Clinical characteristics of hantavirus infections on the Eurasian continent. Curr Top Microbiol Immunol, 256, 135–151.
  • Lozano ME, Enría D, Maiztegui JI, Grau O, Romanowski V. (1995). Rapid diagnosis of Argentine hemorrhagic fever by reverse transcriptase PCR-based assay. J Clin Microbiol, 33, 1327–1332.
  • Lu PL, Tseng SH. (2005). Fatal septicemic melioidosis in a young military person possibly co-infected with Leptospira interrogans and Orientia tsutsugamushi. Kaohsiung J Med Sci, 21, 173–178.
  • Lukes RJ. (1954). The pathology of thirty-nine fatal cases of epidemic hemorrhagic fever. Am J Med, 16, 639–650.
  • Macher AM, Wolfe MS. (2006). Historical Lassa fever reports and 30-year clinical update. Emerging Infect Dis, 12, 835–837.
  • Maes P, Clement J, Gavrilovskaya I, Van Ranst M. (2004). Hantaviruses: immunology, treatment, and prevention. Viral Immunol, 17, 481–497.
  • Maes P, Clement J, Van Ranst M. (2009a). Recent approaches in hantavirus vaccine development. Expert Rev Vaccines, 8, 67–76.
  • Maes P, Keyaerts E, Li S, Nlandu-Masunda V, Clement J, Van Ranst M. (2009b). Replication reduction neutralization test, a quantitative RT-PCR-based technique for the detection of neutralizing hantavirus antibodies. J Virol Methods, 159, 295–299.
  • Maiztegui JI, McKee KT Jr, Barrera Oro JG, Harrison LH, Gibbs PH, Feuillade MR, Enria DA, Briggiler AM, Levis SC, Ambrosio AM, Halsey NA, Peters CJ. (1998). Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. AHF Study Group. J Infect Dis, 177, 277–283.
  • Makela S, Kokkonen L, Ala-Houhala I, Groundstroem K, Harmoinen A, Huhtala H, Hurme M, Paakkala A, Porsti I, Virtanen V, Vaheri A, Mustonen J. (2009). More than half of the patients with acute Puumala hantavirus infection have abnormal cardiac findings. Scand J Infect Dis, 41, 57–62.
  • Markotic A, Kuzman I, Babic K, Gagro A, Nichol S, Ksiazek TG, Rabatic S, Dekaris D. (2002). Double trouble: hemorrhagic fever with renal syndrome and leptospirosis. Scand J Infect Dis, 34, 221–224.
  • Martinez VP, Bellomo C, San Juan J, Pinna D, Forlenza R, Elder M, Padula PJ. (2005). Person-to-person transmission of Andes virus. Emerging Infect Dis, 11, 1848–1853.
  • Martinez-Lopez DG, Fahey M, Coburn J. (2010). Responses of human endothelial cells to pathogenic and non-pathogenic Leptospira species. PLoS Negl Trop Dis, 4, e918.
  • McCormick JB. (1986a). Clinical, epidemiologic, and therapeutic aspects of Lassa fever. Med Microbiol Immunol, 175, 153–155.
  • McCormick JB, King IJ, Webb PA, Johnson KM, O’Sullivan R, Smith ES, Trippel S, Tong TC. (1987). A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis, 155, 445–455.
  • McCormick JB, King IJ, Webb PA, Scribner CL, Craven RB, Johnson KM, Elliott LH, Belmont-Williams R. (1986b). Lassa fever. Effective therapy with ribavirin. N Engl J Med, 314, 20–26.
  • McKee KT Jr, Huggins JW, Trahan CJ, Mahlandt BG. (1988). Ribavirin prophylaxis and therapy for experimental argentine hemorrhagic fever. Antimicrob Agents Chemother, 32, 1304–1309.
  • Medeiros Fda R, Spichler A, Athanazio DA. (2010). Leptospirosis-associated disturbances of blood vessels, lungs and hemostasis. Acta Trop, 115, 155–162.
  • Mertz GJ, Hjelle B, Crowley M, Iwamoto G, Tomicic V, Vial PA. (2006). Diagnosis and treatment of new world hantavirus infections. Curr Opin Infect Dis, 19, 437–442.
  • Mertz GJ, Miedzinski L, Goade D, Pavia AT, Hjelle B, Hansbarger CO, Levy H, Koster FT, Baum K, Lindemulder A, Wang W, Riser L, Fernandez H, Whitley RJ; Collaborative Antiviral Study Group. (2004). Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America. Clin Infect Dis, 39, 1307–1313.
  • Miettinen MH, Mäkelä SM, Ala-Houhala IO, Huhtala HS, Kööbi T, Vaheri AI, Pasternack AI, Pörsti IH, Mustonen JT. (2006). Ten-year prognosis of Puumala hantavirus-induced acute interstitial nephritis. Kidney Int, 69, 2043–2048.
  • Molinas FC, de Bracco MM, Maiztegui JI. (1989). Hemostasis and the complement system in Argentine hemorrhagic fever. Rev Infect Dis, 11 Suppl 4, S762–S770.
  • Monahan AM, Miller IS, Nally JE. (2009). Leptospirosis: risks during recreational activities. J Appl Microbiol, 107, 707–716.
  • Monath TP, Maher M, Casals J, Kissling RE, Cacciapuoti A. (1974). Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. II. Clinical observations and virological studies on selected hospital cases. Am J Trop Med Hyg, 23, 1140–1149.
  • Moolenaar RL, Dalton C, Lipman HB, Umland ET, Gallaher M, Duchin JS, Chapman L, Zaki SR, Ksiazek TG, Rollin PE. (1995). Clinical features that differentiate hantavirus pulmonary syndrome from three other acute respiratory illnesses. Clin Infect Dis, 21, 643–649.
  • Morgan J, Bornstein SL, Karpati AM, Bruce M, Bolin CA, Austin CC, Woods CW, Lingappa J, Langkop C, Davis B, Graham DR, Proctor M, Ashford DA, Bajani M, Bragg SL, Shutt K, Perkins BA, Tappero JW; Leptospirosis Working Group. (2002). Outbreak of leptospirosis among triathlon participants and community residents in Springfield, Illinois, 1998. Clin Infect Dis, 34, 1593–1599.
  • Morse SS. (1994). Hantaviruses and the hantavirus outbreak in the United States. A case study in disease emergence. Ann N Y Acad Sci, 740, 199–207.
  • Mustonen J, Brummer-Korvenkontio M, Hedman K, Pasternack A, Pietilä K, Vaheri A. (1994a). Nephropathia epidemica in Finland: a retrospective study of 126 cases. Scand J Infect Dis, 26, 7–13.
  • Mustonen J, Huttunen NP, Brummer-Korvenkontio M, Vaheri A. (1994b). Clinical picture of nephropathia epidemica in children. Acta Paediatr, 83, 526–529.
  • Narita M, Fujitani S, Haake DA, Paterson DL. (2005). Leptospirosis after recreational exposure to water in the Yaeyama islands, Japan. Am J Trop Med Hyg, 73, 652–656.
  • Ogbu O, Ajuluchukwu E, Uneke CJ. (2007). Lassa fever in West African sub-region: an overview. J Vector Borne Dis, 44, 1–11.
  • Olsson GE, Dalerum F, Hörnfeldt B, Elgh F, Palo TR, Juto P, Ahlm C. (2003). Human hantavirus infections, Sweden. Emerging Infect Dis, 9, 1395–1401.
  • Olsson GE, Leirs H, Henttonen H. (2010). Hantaviruses and their hosts in Europe: reservoirs here and there, but not everywhere? Vector Borne Zoonotic Dis, 10, 549–561.
  • Outinen TK, Mäkelä SM, Ala-Houhala IO, Huhtala HS, Hurme M, Paakkala AS, Pörsti IH, Syrjänen JT, Mustonen JT. (2010). The severity of Puumala hantavirus induced nephropathia epidemica can be better evaluated using plasma interleukin-6 than C-reactive protein determinations. BMC Infect Dis, 10, 132.
  • Panaphut T, Domrongkitchaiporn S, Vibhagool A, Thinkamrop B, Susaengrat W. (2003). Ceftriaxone compared with sodium penicillin g for treatment of severe leptospirosis. Clin Infect Dis, 36, 1507–1513.
  • Panning M, Emmerich P, Olschläger S, Bojenko S, Koivogui L, Marx A, Lugala PC, Günther S, Bausch DG, Drosten C. (2010). Laboratory diagnosis of Lassa fever, liberia. Emerging Infect Dis, 16, 1041–1043.
  • Pappas G, Papadimitriou P, Siozopoulou V, Christou L, Akritidis N. (2008). The globalization of leptospirosis: worldwide incidence trends. Int J Infect Dis, 12, 351–357.
  • Pavli A, Maltezou HC. (2008). Travel-acquired leptospirosis. J Travel Med, 15, 447–453.
  • Peco-Antic A, Popovic-Rolovic M, Gligic A, Popovic D, Jovanovic O, Kostic M. (1992). Clinical characteristics of haemorrhagic fever with renal syndrome in children. Pediatr Nephrol, 6, 335–338.
  • Pekic S, Cvijovic G, Stojanovic M, Kendereski A, Micic D, Popovic V. (2005). Hypopituitarism as a late complication of hemorrhagic fever. Endocrine, 26, 79–82.
  • Pettersson L, Klingström J, Hardestam J, Lundkvist A, Ahlm C, Evander M. (2008). Hantavirus RNA in saliva from patients with hemorrhagic fever with renal syndrome. Emerging Infect Dis, 14, 406–411.
  • Pini N. (2004). Hantavirus pulmonary syndrome in Latin America. Curr Opin Infect Dis, 17, 427–431.
  • Plank R, Dean D. (2000). Overview of the epidemiology, microbiology, and pathogenesis of Leptospira spp. in humans. Microbes Infect, 2, 1265–1276.
  • Plyusnina A, Laakkonen J, Niemimaa J, Henttonen H, Plyusnin A. (2008). New Genetic Lineage of Tula Hantavirus in Microtus arvalis obscurus in Eastern Kazakhstan. Open Virol J, 2, 32–36.
  • Qian DY, Ding YS, Chen GF, Ding JJ, Chen YX, Lu TF, Wang ZX, Smego RA Jr. (1990). A placebo-controlled clinical trial of prednisone in the treatment of early hemorrhagic fever. J Infect Dis, 162, 1213–1214.
  • Ramos MM, Overturf GD, Crowley MR, Rosenberg RB, Hjelle B. (2001). Infection with Sin Nombre hantavirus: clinical presentation and outcome in children and adolescents. Pediatrics, 108, E27.
  • Rasmuson J, Pourazar J, Linderholm M, Sandström T, Blomberg A, Ahlm C. (2011). Presence of activated airway T lymphocytes in human puumala hantavirus disease. Chest, 140, 715–722.
  • Rasmuson J, Andersson C, Norrman E, Haney M, Evander M, Ahlm C. (2011b). Time to revise the paradigm of hantavirus syndromes? Hantavirus pulmonary syndrome caused by European hantavirus. Eur J Clin Microbiol Infect Dis, 30, 685–690.
  • Ratnam S, Sundararaj T, Subramanian S. (1983). Serological evidence of leptospirosis in a human population following an outbreak of the disease in cattle. Trans R Soc Trop Med Hyg, 77, 94–98.
  • Richmond JK, Baglole DJ. (2003). Lassa fever: epidemiology, clinical features, and social consequences. BMJ, 327, 1271–1275.
  • Rivers MN, Alexander JL, Rohde RE, Pierce JR Jr. (2009). Hantavirus pulmonary syndrome in Texas: 1993-2006. South Med J, 102, 36–41.
  • Rusnak JM, Byrne WR, Chung KN, Gibbs PH, Kim TT, Boudreau EF, Cosgriff T, Pittman P, Kim KY, Erlichman MS, Rezvani DF, Huggins JW. (2009). Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea. Antiviral Res, 81, 68–76.
  • Safronetz D, Lopez JE, Sogoba N, Traore’ SF, Raffel SJ, Fischer ER, Ebihara H, Branco L, Garry RF, Schwan TG, Feldmann H. (2010). Detection of Lassa virus, Mali. Emerging Infect Dis, 16, 1123–1126.
  • Salas RA, de Manzione N, Tesh R. (1998). [Venezuelan hemorrhagic fever: eight years of observation]. Acta Cient Venez, 49 Suppl 1, 46–51.
  • Saluzzo JF, Adam F, McCormick JB, Digoutte JP. (1988). Lassa fever virus in Senegal. J Infect Dis, 157, 605.
  • Sasaki DM, Pang L, Minette HP, Wakida CK, Fujimoto WJ, Manea SJ, Kunioka R, Middleton CR. (1993). Active surveillance and risk factors for leptospirosis in Hawaii. Am J Trop Med Hyg, 48, 35–43.
  • Schlegel M, Klempa B, Auste B, Bemmann M, Schmidt-Chanasit J, Büchner T, Groschup MH, Meier M, Balkema-Buschmann A, Zoller H, Krüger DH, Ulrich RG. (2009). Dobrava-belgrade virus spillover infections, Germany. Emerging Infect Dis, 15, 2017–2020.
  • Schmaljohn C. (2009). Vaccines for hantaviruses. Vaccine, 27 Suppl 4, D61–D64.
  • Schultze D, Lundkvist A, Blauenstein U, Heyman P. (2002). Tula virus infection associated with fever and exanthema after a wild rodent bite. Eur J Clin Microbiol Infect Dis, 21, 304–306.
  • Senior K. (2010). Leptospirosis and Weil’s syndrome: cause for concern? Lancet Infect Dis, 10, 823–824.
  • Settergren B. (1991). Nephropathia epidemica (hemorrhagic fever with renal syndrome) in Scandinavia. Rev Infect Dis, 13, 736–744.
  • Settergren B. (2000). Clinical aspects of nephropathia epidemica (Puumala virus infection) in Europe: a review. Scand J Infect Dis, 32, 125–132.
  • Simões J, de Azevedo JF, Palmeiro JM. (1969). Some aspects of the Weil’s disease epidemiology based on a recent epidemic after a flood in Lisbon (1967). An Esc Nacl Saude Publica Med Trop (Lisb), 3, 19–32.
  • Singh MP, Majumdar M, Sharma A, Chawla Y, Ratho RK. (2012). Prolonged jaundice attributed to super infection of hepatitis E virus in a case of resolving leptospirosis. Indian J Med Microbiol, 30, 103–106.
  • Smits HL, Chee HD, Eapen CK, Kuriakose M, Sugathan S, Gasem MH, Yersin C, Sakasi D, Lai-A-Fat RF, Hartskeerl RA, Liesdek B, Abdoel TH, Goris MG, Gussenhoven GC. (2001a). Latex based, rapid and easy assay for human leptospirosis in a single test format. Trop Med Int Health, 6, 114–118.
  • Smits HL, Eapen CK, Sugathan S, Kuriakose M, Gasem MH, Yersin C, Sasaki D, Pujianto B, Vestering M, Abdoel TH, Gussenhoven GC. (2001b). Lateral-flow assay for rapid serodiagnosis of human leptospirosis. Clin Diagn Lab Immunol, 8, 166–169.
  • Song G. (1999). Epidemiological progresses of hemorrhagic fever with renal syndrome in China. Chin Med J, 112, 472–477.
  • Stone R. (1993). The mouse-piñon nut connection. Science, 262, 833.
  • Suh DC, Park JS, Park SK, Lee HK, Chang KH. (1995). Pituitary hemorrhage as a complication of hantaviral disease. AJNR Am J Neuroradiol, 16, 175– 8; discussion 179.
  • Sung, HY, Morrison, AM,& O’leary, JT. (2001). Segmenting the Adventure Travel Market by Activities: From the North American Industry Providers’ Perspective. JTTM, 9, 1–20.
  • Tadin A, Turk N, Korva M, Margaletic J, Beck R, Vucelja M, Habuš J, Svoboda P, Avšic Županc T, Henttonen H, Markotic A. (2012). Multiple Co-infections of Rodents with Hantaviruses, Leptospira, and Babesia in Croatia. Vector Borne Zoonotic Dis EPUB ahead of print.
  • Ter Meulen J, Lukashevich I, Sidibe K, Inapogui A, Marx M, Dorlemann A, Yansane ML, Koulemou K, Chang-Claude J, Schmitz H. (1996). Hunting of peridomestic rodents and consumption of their meat as possible risk factors for rodent-to-human transmission of Lassa virus in the Republic of Guinea. Am J Trop Med Hyg, 55, 661–666.
  • Thornley CN, Baker MG, Weinstein P, Maas EW. (2002). Changing epidemiology of human leptospirosis in New Zealand. Epidemiol Infect, 128, 29–36.
  • Trivedi SV, Chavda RK, Wadia PZ, Sheth V, Bhagade PN, Trivedi SP, Clerk AM, Mevawala DM. (2001). The role of glucocorticoid pulse therapy in pulmonary involvement in leptospirosis. J Assoc Physicians India, 49, 901–903.
  • Trivedi SV, Vasava AH, Patel TC, Bhatia LC. (2009). Cyclophosphamide in pulmonary alveolar hemorrhage due to leptospirosis. Indian J Crit Care Med, 13, 79–84.
  • Tsai TF. (1987). Hemorrhagic fever with renal syndrome: clinical aspects. Lab Anim Sci, 37, 419–427.
  • Tullu MS, Karande S. (2009). Leptospirosis in children: a review for family physicians. Indian J Med Sci, 63, 368–378.
  • Vaheri A, Vapalahti O, Plyusnin A. (2008). How to diagnose hantavirus infections and detect them in rodents and insectivores. Rev Med Virol, 18, 277–288.
  • Van CT, Thuy NT, San NH, Hien TT, Baranton G, Perolat P. (1998). Human leptospirosis in the Mekong delta, Viet Nam. Trans R Soc Trop Med Hyg, 92, 625–628.
  • Van Loock F, Thomas I, Clement J, Ghoos S, Colson P. (1999). A case-control study after a hantavirus infection outbreak in the south of Belgium: who is at risk? Clin Infect Dis, 28, 834–839.
  • Vapalahti K, Paunio M, Brummer-Korvenkontio M, Vaheri A, Vapalahti O. (1999). Puumala virus infections in Finland: increased occupational risk for farmers. Am J Epidemiol, 149, 1142–1151.
  • Vapalahti K, Virtala AM, Vaheri A, Vapalahti O. (2010). Case-control study on Puumala virus infection: smoking is a risk factor. Epidemiol Infect, 138, 576–584.
  • Vapalahti O, Mustonen J, Lundkvist A, Henttonen H, Plyusnin A, Vaheri A. (2003). Hantavirus infections in Europe. Lancet Infect Dis, 3, 653–661.
  • Vapalahti O, Plyusnin A, Vaheri A, Henttonen H. (1995). Hantavirus antibodies in European mammalogists. Lancet, 345, 1569.
  • Verity R, Prasad E, Grimsrud K, Artsob H, Drebot M, Miedzinski L, Preiksaitis J. (2000). Hantavirus pulmonary syndrome in northern Alberta, Canada: clinical and laboratory findings for 19 cases. Clin Infect Dis, 31, 942–946.
  • Viel JF, Lefebvre A, Marianneau P, Joly D, Giraudoux P, Upegui E, Tordo N, Hoen B. (2011). Environmental risk factors for haemorrhagic fever with renal syndrome in a French new epidemic area. Epidemiol Infect, 139, 867–874.
  • Vijayachari P, Sehgal SC. (2006). Recent advances in the laboratory diagnosis of leptospirosis and characterisation of leptospires. Indian J Med Microbiol, 24, 320–322.
  • Vinetz JM, Glass GE, Flexner CE, Mueller P, Kaslow DC. (1996). Sporadic urban leptospirosis. Ann Intern Med, 125, 794–798.
  • Wagenaar JF, de Vries PJ, Hartskeerl RA. (2004). Leptospirosis with pulmonary hemorrhage, caused by a new strain of serovar Lai: Langkawi. J Travel Med, 11, 379–381.
  • Wagenaar JF, Falke TH, Nam NV, Binh TQ, Smits HL, Cobelens FG, de Vries PJ. (2004b). Rapid serological assays for leptospirosis are of limited value in southern Vietnam. Ann Trop Med Parasitol, 98, 843–850.
  • Wagenaar JF, Gasem MH, Goris MG, Leeflang M, Hartskeerl RA, van der Poll T, van ‘t Veer C, van Gorp EC. (2009a). Soluble ST2 levels are associated with bleeding in patients with severe Leptospirosis. PLoS Negl Trop Dis, 3, e453.
  • Wagenaar JF, Goris MG, Gasem MH, Isbandrio B, Moalli F, Mantovani A, Boer KR, Hartskeerl RA, Garlanda C, van Gorp EC. (2009b). Long pentraxin PTX3 is associated with mortality and disease severity in severe Leptospirosis. J Infect, 58, 425–432.
  • Wagenaar JF, Goris MG, Sakundarno MS, Gasem MH, Mairuhu AT, de Kruif MD, Ten Cate H, Hartskeerl R, Brandjes DP, van Gorp EC. (2007). What role do coagulation disorders play in the pathogenesis of leptospirosis? Trop Med Int Health, 12, 111–122.
  • Wagenaar JF, Goris MG, Partiningrum DL, Isbandrio B, Hartskeerl RA, Brandjes DP, Meijers JC, Gasem MH, van Gorp EC. (2010). Coagulation disorders in patients with severe leptospirosis are associated with severe bleeding and mortality. Trop Med Int Health, 15, 152–159.
  • Wei YF, Chiu CT, Lai YF, Lai CH, Lin HH. (2011). Successful treatment of septic shock and respiratory failure due to leptospirosis and scrub typhus coinfection with penicillin, levofloxacin, and activated protein C. J Microbiol Immunol Infect. EPUB ahead of print
  • Weiss S, Witkowski PT, Auste B, Nowak K, Weber N, Fahr J, Mombouli JV, Wolfe ND, Drexler JF, Drosten C, Klempa B, Leendertz FH, Kruger DH. (2012). Hantavirus in bat, Sierra Leone. Emerging Infect Dis, 18, 159–161.
  • Winter CH, Brockmann SO, Piechotowski I, Alpers K, an der Heiden M, Koch J, Stark K, Pfaff G. (2009). Survey and case-control study during epidemics of Puumala virus infection. Epidemiol Infect, 137, 1479–1485.
  • Woodruff AW, Monath TP, Mahmoud AA, Pain AK, Morris CA. (1973). Lassa fever in Britain: an imported case. Br Med J, 3, 616–617.
  • Wuthiekanun V, Sirisukkarn N, Daengsupa P, Sakaraserane P, Sangkakam A, Chierakul W, Smythe LD, Symonds ML, Dohnt MF, Slack AT, Day NP, Peacock SJ. (2007). Clinical diagnosis and geographic distribution of leptospirosis, Thailand. Emerging Infect Dis, 13, 124–126.
  • Yanagihara Y, Villanueva SY, Yoshida S, Okamoto Y, Masuzawa T. (2007). Current status of leptospirosis in Japan and Philippines. Comp Immunol Microbiol Infect Dis, 30, 399–413.
  • Yang ZQ, Zhang TM, Zhang MV, Zheng ZM, Hu ZJ, Qu CF, Xiang JM, Huggins JW, Cosgriff TM, Smith JI. (1991). Interruption study of viremia of patients with hemorrhagic fever with renal syndrome in the febrile phase. Chin Med J, 104, 149–153.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.